Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI

Clinical trial NCT01067976 · COMPLETED

Trial details

NCT number: NCT01067976
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Diagnostic Imaging

Start date: 2010-02-01
Primary completion: 2011-07-01
Enrollment: 446

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.